SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
celery
Lv2
110 积分
2022-07-04 加入
最近求助
最近应助
互助留言
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2个月前
已完结
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
2个月前
已完结
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancer
2个月前
已完结
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
2个月前
已完结
An updated patent review of small-molecule c-Met kinase inhibitors (2018-present)
2个月前
已完结
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
4个月前
已完结
HER2 and lung cancer
4个月前
已完结
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
9个月前
已完结
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
9个月前
已完结
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
10个月前
已完结
没有进行任何应助
已经不需要了【积分已退回】
1年前
暂不需要此文献【积分已退回】
1年前
感谢
1年前
感谢听友的帮助
1年前
感谢
1年前
学术中心有收录【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论